ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,262Medicare Part D Prescriptions Filled, Including Refills

Rank: 31 out of 2429

$893K Total Retail Price of All Prescriptions

Rank: 61 out of 2429

614 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 614 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

16% of this provider’s 614 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 18,274 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
LEVOTHYROXINE SODIUM 714 596 1 3
SIMVASTATIN 671 603 2 1
LOSARTAN POTASSIUM 640 592 3 22
LISINOPRIL 595 527 4 2
FUROSEMIDE 554 516 5 5
POTASSIUM CHLORIDE 510 488 6 14
OMEPRAZOLE 510 493 6 7
AMLODIPINE BESYLATE 498 496 8 4
HYDROCHLOROTHIAZIDE 475 438 9 10
GABAPENTIN 437 392 10 18
HYDROCODONE-ACETAMINOPHEN 425 379 S3 11 6
METOPROLOL TARTRATE 415 380 12 9
CITALOPRAM HBR 396 361 13 19
WARFARIN SODIUM 388 337 14 11
METFORMIN HCL 375 310 15 8
METOPROLOL SUCCINATE 361 336 16 12
DONEPEZIL HCL 297 297 17 26
LOVASTATIN 253 247 18 30
ZOLPIDEM TARTRATE 251 189 19 28
NAMENDA 238 238 20 35
ALENDRONATE SODIUM 217 215 21 20
ATORVASTATIN CALCIUM 215 191 22 13
LOSARTAN-HYDROCHLOROTHIAZIDE 210 207 23 73
TRAMADOL HCL 206 148 24 17
GLIPIZIDE 204 202 25 47
ZETIA 204 192 25 70
ISOSORBIDE MONONITRATE ER 175 173 27 55
PRAVASTATIN SODIUM 169 148 28 16
PANTOPRAZOLE SODIUM 165 164 29 34
PREDNISONE 154 142 30 38
ALLOPURINOL 149 135 31 33
ATENOLOL 145 140 32 15
SPIRIVA 143 124 33 54
RANITIDINE HCL 140 123 34 24
CARVEDILOL 138 130 35 21
LANTUS SOLOSTAR 131 101 36 100
LISINOPRIL-HYDROCHLOROTHIAZIDE 128 128 37 27
FAMOTIDINE 128 107 37 42
RISPERIDONE 126 115 39 52
DILTIAZEM 24HR CD 125 102 40 94
KLOR-CON M20 122 91 41 60
LEVOFLOXACIN 120 112 42 87
TRIAMTERENE-HCTZ 120 109 42 53
PROAIR HFA 119 97 44 41
CLOPIDOGREL 116 114 45 31
PEN NEEDLE 115 93 46 151
AZITHROMYCIN 114 108 47 46
TAMSULOSIN HCL 113 98 48 29
PAROXETINE HCL 112 90 49 67
DIGOXIN 108 107 50 43
MELOXICAM 105 77 51 40
POLYETHYLENE GLYCOL 3350 100 94 52 56
HUMALOG 100 89 52 140
NABUMETONE 99 89 54 96
VYTORIN 94 83 55 200
SERTRALINE HCL 92 81 56 23
CILOSTAZOL 91 73 57 267
BENICAR 89 82 58 164
CLONIDINE HCL 89 89 58 68
DIOVAN 88 79 60 36
ROPINIROLE HCL 88 86 60 92
NEXIUM 87 74 62 37
SINGULAIR 85 77 63 86
DOXAZOSIN MESYLATE 84 84 64 105
PHENYTOIN SODIUM EXTENDED 83 71 65 108
ESCITALOPRAM OXALATE 82 62 66 74
OXYBUTYNIN CHLORIDE 80 61 67 122
SPIRONOLACTONE 78 78 68 62
MECLIZINE HCL 77 77 69 131
CIPROFLOXACIN HCL 77 74 69 84
FELODIPINE ER 75 50 71 141
LYRICA 73 39 72 95
SYNTHROID 72 72 73 93
FLUTICASONE PROPIONATE 72 61 73 39
CYMBALTA 72 42 73 58
PLAVIX 71 71 76 44
COUMADIN 69 62 77 198
ADVAIR DISKUS 66 56 78 49
LANTUS 65 57 79 45
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 55 80 102
NOVOLOG FLEXPEN 59 37 81 215
EVISTA 58 58 82 185
DILTIAZEM 24HR ER 58 50 82 137
GEMFIBROZIL 58 58 82 107
ALBUTEROL SULFATE 58 52 82 129
BENAZEPRIL HCL 56 56 86 80
FENTANYL 56 54 S2 86 59
KLOR-CON M10 55 55 88 139
BYETTA 54 54 89 485
CYCLOBENZAPRINE HCL 54 44 R 89 69
MEGESTROL ACETATE 53 53 R 91 165
NYSTATIN 52 36 92 167
PRIMIDONE 52 52 92 233
GLIMEPIRIDE 51 51 94 51
CRESTOR 51 50 94 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.